• Barinthus Biotherapeutics will hold its annual general meeting in London on July 2, 2026.
• Shareholders will vote on the re-election of directors Karen T. Dawes and Anne M. Phillips.
• Items also include PricewaterhouseCoopers’ reappointment as U.K. statutory auditor, ratification as independent registered public accounting firm, and approval of auditor remuneration.
• The meeting will cover receipt of the U.K. statutory annual accounts and reports for the year ended Dec. 31, 2025.
• Shareholders will cast an advisory vote on the U.K. statutory directors’ annual compensation report for 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Barinthus Biotherapeutics plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-072410), on June 10, 2026, and is solely responsible for the information contained therein.